{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:40:10Z","timestamp":1789090810223,"version":"build-2803163510"},"reference-count":134,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.arcmed.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T17:27:45Z","timestamp":1644514065000},"page":"240-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neuroendocrine-immune Interface: Interactions of Two Complex Systems in Health and Disease"],"prefix":"10.1016","volume":"53","author":[{"given":"Sandra","family":"Vela-Pati\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Isabel","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Remba-Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Pe\u00f1a-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Silva-Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Andoneui-Elguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose de Jesus","family":"Ordo\u00f1ez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Taniguchi-Ponciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonifaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Aguilar-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marrero-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2022.01.003_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-Neuro-Endocrine Interactions: Facts and Hypotheses","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.immunol.20.082401.104914","article-title":"Neuroendocrine regulation of immunity","volume":"20","author":"Webster","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0003","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1196\/annals.1351.011","article-title":"Neuroendocrine-immune interactions: The role of Cortistatin\/somatostatin system","volume":"1069","author":"Ferone","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2021.655982","article-title":"Dynamic Interactions Between the Immune System and the Neuroendocrine System in Health and Disease","volume":"12","author":"Klein","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0006","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11060-020-03636-z","article-title":"Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas","volume":"149","author":"Zhou","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0007","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/j.2040-4603.2016.tb00708.x","article-title":"Hypothalamus-Pituitary-Thyroid Axis","volume":"6","author":"Ortiga-Carvalho","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0008","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/153537020623100301","article-title":"The immune system as a regulator of thyroid hormone activity","volume":"231","author":"Klein","year":"2006","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0009","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/cimm.2001.1846","article-title":"Rapid and transient reduction in circulating thyroid hormones following systemic antigen priming: Implications for functional collaboration between dendritic cells and thyroid","volume":"212","author":"Bagriacik","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0010","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.4049\/jimmunol.164.12.6158","article-title":"The Thyrotropin (Thyroid-Stimulating Hormone) Receptor Is Expressed on Murine Dendritic Cells and on a Subset of CD45RB high Lymph Node T Cells: Functional Role for Thyroid-Stimulating Hormone During Immune Activation","volume":"164","author":"Ba\u011fria\u00e7ik","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/thy.2010.0183","article-title":"Thyroid hormones influence human dendritic cells\u2019 phenotype, function, and subsets distribution","volume":"21","author":"Dedecjus","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0012","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jcem-62-3-474","article-title":"Thyroid function modulates thymic endocrine activity","volume":"62","author":"Fabris","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0013","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.4049\/jimmunol.157.8.3334","article-title":"Defective B cell development in Snell dwarf (dw\/dw) mice can be corrected by thyroxine treatment","volume":"157","author":"Montecino-Rodriguez","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0014","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ajpath.2013.10.006","article-title":"The thyroid hormone triiodothyronine controls macrophage maturation and functions: Protective role during inflammation","volume":"184","author":"Perrotta","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0015","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1073\/pnas.1017624108","article-title":"Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity","volume":"108","author":"Al-Abed","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/gene.2008.69","article-title":"Bone marrow cells produce a novel TSH\u03b2 splice variant that is upregulated in the thyroid following systemic virus infection","volume":"10","author":"Vincent","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0146111","article-title":"Splenic leukocytes traffic to the thyroid and produce a novel TSH\u03b2 isoform during acute Listeria monocytogenes infection in mice","volume":"11","author":"Montufar-Solis","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0018","first-page":"4514","article-title":"HPT axis\u2011independent TSH\u03b2 splice variant regulates the synthesis of thyroid hormone in mice","volume":"49","author":"Liu","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0019","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1007\/s11033-012-1871-x","article-title":"A newly identified TSH\u03b2 splice variant is involved in the pathology of Hashimoto's thyroiditis","volume":"39","author":"Liu","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12703\/r\/10-41","article-title":"Recent advances in understanding gonadotropin signaling","volume":"10","author":"Casarini","year":"2021","journal-title":"Fac Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/er.2018-00065","article-title":"Two hormones for one receptor: Evolution, biochemistry, actions, and pathophysiology of LH and hCG","volume":"39","author":"Casarini","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/NIB-2012-012039","article-title":"Estrogen and Signaling in the Cells of Immune System","volume":"3","author":"Khan","year":"2012","journal-title":"Adv Neuroimmune Biol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2567.2001.01212.x","article-title":"Role of oestrogen receptors \u03b1 and \u03b2 in immune organ development and in oestrogen-mediated effects on thymus","volume":"103","author":"Erlandsson","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0024","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0731830100","article-title":"Disruption of the estrogen receptor \u03b2 gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis","volume":"100","author":"Shim","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrendo.2011.122","article-title":"The G protein-coupled estrogen receptor GPER in health and disease","volume":"7","author":"Prossnitz","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3819","article-title":"The role of sex hormones in immune protection of the female reproductive tract","volume":"15","author":"Wira","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00635","article-title":"The immune system is a natural target for estrogen action: Opposing effects of estrogen in two prototypical autoimmune diseases","volume":"6","author":"Khan","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12016-010-8199-x","article-title":"Estrogen and Autoimmune Disease","volume":"40","author":"Walker","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0079-6123(09)17516-7","article-title":"Estrogen and testosterone therapies in multiple sclerosis","volume":"175","author":"Gold","year":"2009","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0031","first-page":"419","article-title":"A new hypothesis of the possible mechanisms of gender differences in systemic lupus erythematosus","volume":"28","author":"Sekigawa","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0032","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1677\/joe.1.06565","article-title":"Expression and localization of the progesterone receptor in mouse and human reproductive organs","volume":"191","author":"Teilmann","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0033","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/me.2006-0112","article-title":"Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-\u03baB activation of cyclooxygenase 2 expression","volume":"20","author":"Hardy","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0034","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.imlet.2009.07.003","article-title":"Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-\u03baB activation and enhancing SOCS1 expression","volume":"125","author":"Su","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0035","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.0901155","article-title":"Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone","volume":"185","author":"Jones","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0036","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.4049\/jimmunol.180.8.5746","article-title":"NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis","volume":"180","author":"Arruvito","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0037","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.168.3.1087","article-title":"Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids","volume":"168","author":"Miyaura","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0038","first-page":"123","article-title":"Mouse endometrial stromal cells and progesterone inhibit the activation and regulate the differentiation and antibody secretion of mouse B cells","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/acb.2012.012159","article-title":"Clinical biochemistry of dihydrotestosterone","volume":"50","author":"Marchetti","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0040","first-page":"3","article-title":"Androgen Receptor Structure, Function and Biology: From Bench to Bedside","volume":"37","author":"Davey","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0041","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.biocel.2009.11.013","article-title":"Molecular cell biology of androgen receptor signalling","volume":"42","author":"Bennett","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0042","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.167.4.2060","article-title":"Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production","volume":"167","author":"Liva","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0043","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/endo.142.3.8032","article-title":"Androgen receptors in thymic epithelium modulate thymus size and thymocyte development","volume":"142","author":"Olsen","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0044","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.20082521","article-title":"Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor","volume":"206","author":"Chuang","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0045","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men","volume":"89","author":"Malkin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0046","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1095\/biolreprod.107.063545","article-title":"Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity","volume":"78","author":"Rettew","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0047","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2018.00794","article-title":"Androgen-Induced Immunosuppression","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0048","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI200113183","article-title":"Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development","volume":"108","author":"Olsen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0049","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/edrv-12-4-424","article-title":"Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins","volume":"12","author":"Baumann","year":"1991","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ando.2017.04.002","article-title":"Biology of the somatotroph axis (after the pituitary)","volume":"78","author":"Rosenfeld","year":"2017","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0051","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-21-0087","article-title":"The growth hormone-insulin like growth factor axis in pregnancy","author":"Kaur","year":"2021","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0052","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.beem.2015.06.004","article-title":"Growth hormone binding protein - physiological and analytical aspects","volume":"29","author":"Schilbach","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0053","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","article-title":"Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly","volume":"23","author":"Kopchick","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111075","article-title":"GHR signalling: Receptor activation and degradation mechanisms","volume":"520","author":"Chhabra","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0055","first-page":"731","article-title":"Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues","volume":"78","author":"Mercado","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0056","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1749-6632.2000.tb05418.x","article-title":"Growth Hormone and Prolactin Expression in the Immune System","volume":"917","author":"Ron","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0057","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cellimm.2011.06.001","article-title":"High molecular weight isoforms of growth hormone in cells of the immune system","volume":"271","author":"Weigent","year":"2011","journal-title":"Cell Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0058","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cellimm.2013.10.003","article-title":"Lymphocyte GH-axis hormones in immunity","volume":"285","author":"Weigent","year":"2013","journal-title":"Cell Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0059","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygcen.2014.11.004","article-title":"Autocrine\/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview","volume":"220","author":"Harvey","year":"2015","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0060","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0061","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"STAT5B deficiency: Impacts on human growth and immunity","volume":"28","author":"Hwa","year":"2016","journal-title":"Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0062","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fnins.2020.00621","article-title":"Secretion and Function of Pituitary Prolactin in Evolutionary Perspective","volume":"14","author":"Dobolyi","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0063","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0064","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41574-019-0194-6","article-title":"Prolactin - a pleiotropic factor in health and disease","volume":"15","author":"Bernard","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101324","article-title":"Prolactin and autoimmunity: The hormone as an inflammatory cytokine","volume":"33","author":"Borba","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0066","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/endrev\/bnaa002","article-title":"Dynamics of ACTH and Cortisol Secretion and Implications for Disease","volume":"41","author":"Lightman","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0067","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.beem.2018.02.002","article-title":"Pathophysiology of melanocortin receptors and their accessory proteins","volume":"32","author":"Novoselova","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0068","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1073\/pnas.89.2.782","article-title":"Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection","volume":"89","author":"Smith","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0069","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10571-005-3972-8","article-title":"ACTH Enhancement of T-Lymphocyte Cytotoxic Responses","volume":"25","author":"Johnson","year":"2005","journal-title":"Cell Mol Neurobio"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.010","article-title":"New causes of hypophysitis","volume":"33","author":"Yuen","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101371","article-title":"Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation","volume":"33","author":"Gubbi","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0073","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/17446651.2019.1598260","article-title":"Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease","volume":"14","author":"Wehbeh","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0074","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-018-9480-1","article-title":"Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions","volume":"19","author":"Gubbi","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","article-title":"Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects","volume":"19","author":"Bellastella","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0076","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/02688690120057664","article-title":"Lymphocytic and granulocytic hypophysitis: A single centre experience","volume":"15","author":"Buxton","year":"2001","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0077","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4103\/2230-8210.122608","article-title":"Pregnancy and pituitary disorders: Challenges in diagnosis and management","volume":"17","author":"Laway","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0078","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.pas.0000149707.12335.8e","article-title":"Immunopathology of primary hypophysitis: Implications for pathogenesis","volume":"29","author":"Gutenberg","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0079","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000452905","article-title":"Pituitary Autoimmunity","volume":"48","author":"Guaraldi","year":"2017","journal-title":"Front Horm Res"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2249.2008.03828.x","article-title":"T regulatory cells distinguish two types of primary hypophysitis","volume":"155","author":"Mirocha","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0081","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jc.87.2.752","article-title":"Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as \u03b1-enolase","volume":"87","author":"O'Dwyer","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0082","first-page":"288","article-title":"Antipituitary antibodies in patients with lymphocytic hypophysitis","volume":"55","author":"Takao","year":"2001","journal-title":"Horm Res"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0083","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1076\/apab.110.1.94.897","article-title":"Pituitary autoantibodies in lymphocytic hypophysitis target both \u03b3- and \u03b1-enolase - A link with pregnancy?","volume":"110","author":"O'Dwyer","year":"2002","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0084","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1210\/jc.2012-2269","article-title":"Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: Role of antibodies to hypothalamic cells","volume":"97","author":"De Bellis","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1507\/endocrj.EJ17-0028","article-title":"Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy","volume":"64","author":"Sakurai","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0086","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","article-title":"Isolated corticotrophin deficiency","volume":"9","author":"Andrioli","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0087","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-15-0766","article-title":"Longitudinal behavior of autoimmune GH deficiency: From childhood to transition age","volume":"174","author":"De Bellis","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0088","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1210\/jc.2013-2411","article-title":"Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells","volume":"98","author":"Iwama","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0089","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2013.10.009","article-title":"Pituitary gonadotropins and autoimmunity","volume":"385","author":"Cocco","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/07435800902841306","article-title":"Empty sella may be the final outcome in lymphocytic hypophysitis","volume":"34","author":"Karaca","year":"2009","journal-title":"Endocr Res"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0091","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1210\/jc.2015-2702","article-title":"HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis","volume":"100","author":"Heaney","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0092","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0093","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0094","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy-immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-Related Adverse Events Associated with Immune Checkpoint Blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0096","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41574-021-00484-3","article-title":"Endocrine toxicities of immune checkpoint inhibitors","volume":"17","author":"Wright","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-020-02656-7","article-title":"Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report","volume":"15","author":"Kikuchi","year":"2021","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0098","first-page":"98","article-title":"CTLA-4 and PD-1 pathways similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0099","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-14-0845","article-title":"Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma","volume":"172","author":"Albarel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-19-0238","article-title":"Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis","volume":"181","author":"Faje","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0102","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2014-2306","article-title":"Ipilimumab-induced hypophysitis: A detailed longitudinal analysis in a large cohort of patients with metastatic melanoma","volume":"99","author":"Faje","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1078-0432.CCR-14-2353","article-title":"Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: A retrospective cohort study","volume":"21","author":"Min","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0105","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.ajpath.2016.08.020","article-title":"Hypophysitis Secondary to Cytotoxic T-Lymphocyte\u2013Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series","volume":"186","author":"Caturegli","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0106","doi-asserted-by":"crossref","first-page":"230ra45","DOI":"10.1126\/scitranslmed.3008002","article-title":"Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody","volume":"6","author":"Iwama","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0107","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"Mechanisms of disease: IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: Features and treatment response in a French cohort: Results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0109","article-title":"IgG4 hypophysitis: Diagnosis and management","volume":"49","author":"Lojou","year":"2020","journal-title":"Press Medicale"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0110","first-page":"1982","article-title":"Clinical characteristics of immunoglobulin G4-related disease: A prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0111","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0112","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/608406","article-title":"Immune microenvironment in tumor progression: characteristics and challenges for therapy","volume":"2012","author":"Chew","year":"2012","journal-title":"J Oncol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0113","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/stem.596","article-title":"Concise review: Mesenchymal tumors: When stem cells go mad","volume":"29","author":"Mohseny","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0115","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0116","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0118","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0119","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/scbi.2001.0419","article-title":"The role of cytokines in the epithelial cancer microenvironment","volume":"12","author":"Wilson","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0121","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0123","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-\u03b3 activities independently control tumor initiation, growth, and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (NK) and NKT cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0140-6736(94)92636-0","article-title":"High incidence of anal cancer among AIDS patients. The AIDS\/Cancer Working Group","volume":"343","author":"Melbye","year":"1994","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0126","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1600-6143.2010.03078.x","article-title":"Melanoma in solid organ transplant recipients","volume":"10","author":"Zwald","year":"2010","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0127","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1210\/edrv.18.2.0297","article-title":"Pituitary cytokine and growth factor expression and action","volume":"18","author":"Ray","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0128","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/030089169007600605","article-title":"Mononuclear Cell Infiltrate and Hla-Dr Expression in 28 Pituitary Adenomas","volume":"76","author":"Rossi","year":"1990","journal-title":"Tumori J"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1507\/endocrj.45.357","article-title":"Prevalence of Lymphocytic Infiltrate in 1400 Pituitary Adenomas","volume":"45","author":"Heshmati","year":"1998","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1385\/EP:12:3:307","article-title":"CD markers in pituitary adenomas","volume":"12","author":"Saeger","year":"2001","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0131","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1210\/jc.2009-1583","article-title":"Tumor infiltrating lymphocytes but not surgery in patients with pituitary adenoma","volume":"95","author":"Lupi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0132","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","article-title":"Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas","volume":"26","author":"Lu","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0133","doi-asserted-by":"crossref","first-page":"E3207","DOI":"10.1210\/clinem\/dgaa449","article-title":"The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2022.01.003_bib0134","doi-asserted-by":"crossref","first-page":"19373","DOI":"10.1038\/s41598-020-76555-8","article-title":"Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors","volume":"10","author":"Taniguchi-Ponciano","year":"2020","journal-title":"Sci Rep"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:51:02Z","timestamp":1759261862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440922000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0188440922000066"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.01.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine-immune Interface: Interactions of Two Complex Systems in Health and Disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}